Publications by authors named "Katherine A Janeway"

Claim this Profile
M
Molecular Characterization Informs Prognosis in Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group.
Riaz Gillani, David S Shulman, Natalie J DelRocco, Kelly Klega, Ruxu Han, Katherine A Janeway

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Associated With Primary Site Local Therapy in Patients With Nonmetastatic Ewing Sarcoma Treated With Interval-Compressed Chemotherapy: A Report From the Children's Oncology Group.
Safia K Ahmed, Odion Binitie, Mark Krailo, Daniel J Indelicato, Alexandra K Callan, Katherine A Janeway

Int J Radiat Oncol Biol Phys· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Implementation of Matched Tumor/Germline Sequencing Improves Accuracy of Tumor Genomic Profiling and Therapeutic Recommendations.
Danielle K Manning, Guruprasad Ananda, Cheryl Eifert, Vanesa Rojas-Rudilla, William Swanton, Katherine A Janeway

J Mol Diagn· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 2 Trial of RANKL Antibody, Denosumab, in Two Cohorts of Patients with Recurrent / Refractory Osteosarcoma, A Report from the Children's Oncology Group (COG).
Katherine A Janeway, Alexander J Chou, Allen Buxton, Joel Reid, Michael S Isakoff

Clin Cancer Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline Cancer Predisposition Results From the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial.
Sarah Scollon, Sharon E Plon, Steven Joffe, Jaclyn A Biegel, Shashikant Kulkarni, Katherine A Janeway

JCO Precis Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SMARCAL1 is a new osteosarcoma predisposition gene.
Maryam Rafati, Lillian M Guenther, Laura E Egolf, D Matthew Gianferante, Jung Kim, Katherine A Janeway

J Natl Cancer Inst· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative Radiotherapy in Patients With Localized Ewing Sarcoma Enrolled on AEWS1031: A Report From the Children's Oncology Group.
Daniel J Indelicato, Alexandra K Callan, Safia K Ahmed, Mark Krailo, Natalie DelRocco, Katherine A Janeway

Pediatr Blood Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Childhood Cancer Data Initiative: Expanded access to tumor molecular profiling for children, adolescents, and young adults.
Joseph Flores-Toro, Subhashini Jagu, Malcolm Smith, John Shern, Douglas S Hawkins, Katherine A Janeway

J Natl Cancer Inst· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supporting Participant Engagement in Cancer Genomics Research in Rare Cancers: A Qualitative Study of Patients, Caregivers, and Advocates.
Vinayak Venkataraman, Lily Weber, Lauren Fisher, Andrew Khalaj, Eirian Siegal-Botti, Katherine A Janeway

Cancer Control· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare germline structural variants increase risk for pediatric solid tumors.
Riaz Gillani, Ryan L Collins, Jett Crowdis, Amanda Garza, Jill K Jones, Katherine A Janeway

Science· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular characterization informs prognosis in patients with localized Ewing sarcoma: A report from the Children's Oncology Group.
Riaz Gillani, David S Shulman, Natalie J DelRocco, Kelly Klega, Ruxu Han, Katherine A Janeway

medRxiv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming Systemic Barriers to Make Patient-Partnered Research a Reality.
Vinayak Venkataraman, Bailey A Martin-Giacalone, Bettina F Drake, Liz Salmi, Elizabeth B Claus, Katherine A Janeway

J Clin Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenvatinib Plus Ifosfamide and Etoposide in Children and Young Adults With Relapsed Osteosarcoma: A Phase 2 Randomized Clinical Trial.
Nathalie Gaspar, Giun-Yi Hung, Sandra J Strauss, Quentin Campbell-Hewson, Filemon S Dela Cruz, Katherine A Janeway

JAMA Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poverty, race, ethnicity, and survival in pediatric nonmetastatic osteosarcoma: a Children's Oncology Group report.
Lenka Ilcisin, Ruxu Han, Mark Krailo, David S Shulman, Brent R Weil, Katherine A Janeway

J Natl Cancer Inst· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Study of Samotolisib in Children and Young Adults With Tumors Harboring Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Pathway Alterations: Pediatric MATCH APEC1621D.
Theodore W Laetsch, Kathleen Ludwig, P Mickey Williams, Sinchita Roy-Chowdhuri, David R Patton, Katherine A Janeway

JCO Precis Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palbociclib in Solid Tumor Patients With Genomic Alterations in the cyclinD-cdk4/6-INK4a-Rb Pathway: Results From National Cancer Institute-Children's Oncology Group Pediatric Molecular Analysis for Therapy Choice Trial Arm I (APEC1621I).
Margaret E Macy, Rajen Mody, Joel M Reid, Jin Piao, Lauren Saguilig, Katherine A Janeway

JCO Precis Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm G.
Marie V Nelson, AeRang Kim, P Mickey Williams, Sinchita Roy-Chowdhuri, David R Patton, Katherine A Janeway

Oncologist· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer.
Suzanne J Forrest, Hersh Gupta, Abigail Ward, Yvonne Y Li, Duong Doan, Katherine A Janeway

Nat Commun· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olaparib for childhood tumors harboring defects in DNA damage repair genes: arm H of the NCI-COG Pediatric MATCH trial.
Julia L Glade Bender, Kerice Pinkney, Paul M Williams, Sinchita Roy-Chowdhuri, David R Patton, Katherine A Janeway

Oncologist· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer.
Suzanne J Forrest, Hersh Gupta, Abigail Ward, Yvonne Y Li, Duong Doan, Katherine A Janeway

Nat Commun· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial.
Meenakshi Hegde, Shoba Navai, Christopher DeRenzo, Sujith K Joseph, Khaled Sanber, Katherine A Janeway

Nat Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Study of Ulixertinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Alterations: APEC1621J of the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial.
Kieuhoa T Vo, Amit J Sabnis, P Mickey Williams, Sinchita Roy-Chowdhuri, David R Patton, Katherine A Janeway

JCO Precis Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 study of cabozantinib in combination with topotecan-cyclophosphamide for patients with relapsed Ewing sarcoma or osteosarcoma.
Kevin Campbell, Andrew Posner, Nan Chen, Kerri Cavanaugh, Ketki Bhushan, Katherine A Janeway

Pediatr Blood Cancer· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: Comment on: A pooled subgroup analysis of glucarpidase treatment in 86 pediatric, adolescent, and young adult patients receiving high-dose methotrexate therapy in open-label trials.
Katherine A Janeway, Luis Gros, Stefan Schwartz, Claire Daugherty, Eva Gallardo

Pediatr Blood Cancer· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innovations in Cancer Treatment of Children.
Lauren Helms, Allison E Guimera, Katherine A Janeway, Kelly M Bailey

Pediatrics· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis